{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:49:47Z","timestamp":1789148987457,"version":"build-2803163510"},"reference-count":9,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["SAGE Open Medical Case Reports"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:p> Pyoderma gangrenosum is a rare inflammatory neutrophilic disorder with no uniformly effective therapy and limited high-level evidence. Common therapies include immunosuppressive and immunomodulating agents. There exist several case series using small molecules as treatment modalities. Here, we report a case of a 78-year-old female with a diagnosis of pyoderma gangrenosum and metastatic high-grade serous carcinoma of the ovary who was treated with Baricitinib 4 mg daily in combination with a tapering course of prednisone after failing other conventional therapies including systemic corticosteroids, colchicine, and intravenous immunoglobulin. <\/jats:p>","DOI":"10.1177\/2050313x241235444","type":"journal-article","created":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T10:03:17Z","timestamp":1711188197000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Use of Baricitinib in a patient with treatment-resistant pyoderma gangrenosum"],"prefix":"10.1177","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1452-9100","authenticated-orcid":false,"given":"Kaylin","family":"Bechard","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Alberta Medicine, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gniadecki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Alberta Medicine, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,3,23]]},"reference":[{"key":"bibr1-2050313X241235444","first-page":"140","volume-title":"Andrews\u2019 diseases of the skin","author":"James WD","year":"2020","edition":"13"},{"key":"bibr2-2050313X241235444","first-page":"453","volume-title":"Dermatology","author":"Davis M","year":"2018","edition":"4"},{"key":"bibr3-2050313X241235444","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0251-7"},{"key":"bibr4-2050313X241235444","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00699-8"},{"key":"bibr5-2050313X241235444","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2023.05.002"},{"key":"bibr6-2050313X241235444","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100099"},{"key":"bibr7-2050313X241235444","doi-asserted-by":"publisher","DOI":"10.1002\/jvc2.62"},{"key":"bibr8-2050313X241235444","unstructured":"National Library of Medicine (U.S.) Baricitinib in the Treatment of Adults with Pyoderma Gangrenosum. Identifier NCT04901325, 25 May 2021. https:\/\/clinicaltrials.gov\/study\/NCT04901325"},{"key":"bibr9-2050313X241235444","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.07.002"}],"container-title":["SAGE Open Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050313X241235444","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2050313X241235444","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050313X241235444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T23:34:35Z","timestamp":1740958475000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2050313X241235444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":9,"alternative-id":["10.1177\/2050313X241235444"],"URL":"https:\/\/doi.org\/10.1177\/2050313x241235444","relation":{},"ISSN":["2050-313X","2050-313X"],"issn-type":[{"value":"2050-313X","type":"print"},{"value":"2050-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"article-number":"2050313X241235444"}}